| Autor: |
ten Hoorn, Sanne, Waasdorp, Cynthia, van Oijen, Martijn G. H., Damhofer, Helene, Trinh, Anne, Zhao, Lan, Smits, Lisanne J. H., Bootsma, Sanne, van Pelt, Gabi W., Mesker, Wilma E., Mol, Linda, Goey, Kaitlyn K. H., Koopman, Miriam, Medema, Jan Paul, Tuynman, Jurriaan B., Zlobec, Inti, Punt, Cornelis J. A., Vermeulen, Louis, Bijlsma, Maarten F. |
| Rok vydání: |
2022 |
| DOI: |
10.6084/m9.figshare.19586860.v1 |
| Popis: |
Additional file 1: Supplementary Table S1. Expression dataset used for analysis. Supplementary Table S2. Prognostic value of ADAM12. Supplementary Table S3. Association of ADAM12 groups with survival, treatment and KRAS and BRAF mutation status. Supplementary Table S4. Prognostic value of ADAM12, stratified by primary tumor location. Supplementary Table S5. Characteristics pilot rectal cancer (n = 20). Supplementary Figure S1. ADAM12 expression correlates with activated stroma signature. Supplementary Figure S2. Multivariate analysis of relevant parameters and overall survival. Supplementary Figure S3. High serum ADAM12 levels associate with unfavorable outcome independent of treatment status. Supplementary Figure S4. Association between ADAM12 serum concentration and percentage tumor epithelium. Supplementary Figure S5. High serum ADAM12 levels associate with unfavorable outcome in mesenchymal tumours. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
